Wednesday, August 30, 2023 12:24 AM
ATLANTA—Visioneering Technologies, Inc.
(ASX:VTI), a U.S.-based medical device company and producer of the NaturalVue Multifocal 1 Day contact lenses, announced the appointment of Dr. Juan Carlos Aragón as chief executive officer and executive director, effective Oct. 1, 2023. Dr. Aragón brings over 30 years of leadership in the vision care industry to VTI. His experience includes senior executive leadership positions in several large international vision care companies, and managing divisions for the Americas, Asia Pacific and Europe.
Monday, July 10, 2023 12:18 AM
has appointed Adam Winkelman as vice president of sales, to spearhead the development and expansion of its photochromic lens category in North America.
Friday, April 7, 2023 12:15 AM
SARATOGA, Calif.—Mojo Vision
, the high-performance micro-LED company, has announced a $22.4 million new Series A investment round to propel the development and commercialization of its micro-LED display technology.
Friday, March 10, 2023 12:21 AM
GREEN BAY, Wis.—Shopko Optical
, a provider of eyecare services across the Midwest for more than 40 years, announced the appointment of Kirk Lauterback to the newly created role of chief experience officer.
Wednesday, March 8, 2023 12:15 AM
ROCHESTER, N.Y.—Neuroscience company Cognivue Inc.
has named neuroscientist Dr. James E. Galvin as its chief scientific officer. He is the founding director of the Comprehensive Center for Brain Health
, professor of neurology, and professor of psychiatry and behavioral sciences at the University of Miami Miller School of Medicine. Dr. Galvin will remain at the University of Miami while assuming his new role at Cognivue, where he has served on the company’s clinical advisory board since March 2022.
Tuesday, March 7, 2023 12:18 AM
, a leading U.S. eyecare pharmaceutical company, announced the appointment of Mark Mannebach, PhD, RPh, as head of regulatory affairs and pharmacovigilance, responsible for overseeing and managing all regulatory related submissions and strategy related to the company’s portfolio of new and existing products.
Tuesday, March 7, 2023 12:15 AM
LONDON and NEW YORK—Eyebiotech Limited
(EyeBio), a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to patients with sight-threatening eye diseases, announced several appointments to its executive team. The company also announced details on Restoret, the first asset in a diversified pipeline of multi-specific agonist antibodies. Restoret is a tri-specific Wnt agonist antibody designed to address medical needs in patients with back-of-the-eye diseases. “We founded EyeBio to capture scientific advances and translate them into effective treatments for patients with serious eye diseases,” said David Guyer, MD, co-founder, CEO, and president of EyeBio.
Monday, January 23, 2023 12:24 AM
NEW YORK—Several new speakers are joining the program roster at the upcoming Vision Monday Leadership Summit
, "Insight, Unseen: How Leaders Uncover, Design and Scale Innovations." The live, in-person event to be held in New York on Wednesday, March 15, 2023, will feature prominent voices and key opinion leaders in communications, business consulting, human resources, retailing and vision care. Their ideas will inform a daylong program designed for senior decision makers and influencers from throughout the optical industry and eyecare professions.
Thursday, January 19, 2023 12:30 AM
NEW YORK—Organizers of the Vision Monday Leadership Summit
announced the first speakers for the annual meeting, including business and health care experts who will offer insights about how leaders of companies and organizations can uncover, design and scale innovations. The VM Summit, a live, in-person event on Wednesday, March 15, 2023, will feature prominent voices and key opinion leaders in communications, business consulting, human resources, retailing and vision care. Their ideas will inform “Insight, Unseen,” a daylong program designed for senior decision makers and influencers from throughout the optical industry and eyecare professions.
Friday, December 30, 2022 12:21 AM
VAUGHAN, Ontario—Bausch + Lomb Corporation
(NYSE/TSX: BLCO) (B+L) announced that the company and its CEO, Joseph C. Papa, have entered into an amended and restated separation agreement.
Monday, November 28, 2022 12:21 AM
LOMBARD, Ill.—Visionix USA
, the manufacturer and marketer of eye health and med tech products formerly known as Luneau Technology
, has promoted John Vulich to national sales manager for finishing, effective immediately.
Friday, November 18, 2022 12:24 AM
OAK BROOK, Ill.—Visionary Optics
, a leader in the design and manufacturing of scleral lenses, has appointed Lynette K. Johns, OD, FAAO, FSLS, FBCLA, to the position of director of clinical and scientific affairs.
Thursday, November 3, 2022 12:24 AM
, a developer of an artificial intelligence-powered wearable device for ophthalmic diagnostics, announced several key executive appointments across its leadership team and board of directors to further strengthen the company’s commercial operation and support its next phase of growth. Fred Drasner, a luminary in enterprise, seasoned venture capitalist, and current Heru board member, has been appointed as Heru’s chairman of the board of directors. Drasner is currently chairman of Three Seasons Capital, a venture capital firm, and has been at the helm of numerous company portfolio exits.